Skip to main content
Hikal Ltd. logo

Hikal Ltd. — Investor Relations & Filings

Ticker · HIKAL ISIN · INE475B01022 LEI · 335800OLTGHHYZWTF859 BSE.NS Manufacturing
Filings indexed 733 across all filing types
Latest filing 2026-05-27 Earnings Release
Country IN India
Listing BSE.NS HIKAL

About Hikal Ltd.

https://www.hikal.com

Hikal Ltd. provides solutions across the life sciences value chain, specializing in the development and manufacturing of active ingredients, intermediates, and formulations. The company operates through two primary business segments: Pharmaceuticals and Crop Protection. In the pharmaceutical division, it focuses on the production of Active Pharmaceutical Ingredients (APIs) and advanced intermediates for various therapeutic areas. The crop protection segment involves the contract manufacturing of pesticides, herbicides, and fungicides for global agrochemical leaders. Hikal offers comprehensive Contract Research and Manufacturing Services (CRAMS), leveraging its research and development capabilities to support clients from early-stage development to commercial-scale production. Its facilities adhere to international quality standards, maintaining a strong track record of regulatory compliance with global health authorities.

Recent filings

Filing Released Lang Actions
Announcement under Regulation 30 (LODR)- Press Release.
Earnings Release Classification · 95% confidence The document is a formal press release of the company’s audited standalone and consolidated financial results for Q4 and full-year FY26, sent to stock exchanges and containing headline metrics (revenue, EBITDA, PAT, EPS), business highlights and a Chairman’s commentary. It is the initial announcement of quarterly/periodical financial results rather than a full interim report with detailed financial statements. Therefore it corresponds to an Earnings Release (ER). FY 2026
2026-05-27 English
Announcement under Reg 30 SEBI(LODR)- Investor Presentation
Investor Presentation Classification · 95% confidence The document is a formal notice under SEBI Regulation 30 enclosing a “Results Presentation” titled “Investor Presentation Q4 & FY26.” It consists of detailed slides with financial summaries, charts, segmental commentary, and strategic outlook – characteristics of a presentation deck rather than a brief earnings release or transcript. Therefore it matches the definition of an Investor Presentation (IP).
2026-05-27 English
Press Release
Earnings Release Classification · 96% confidence The document is an announcement of the audited quarterly and full‐year financial results (Q4 & FY26) including revenue, EBITDA, PAT, segment performance, dividend declaration, and management commentary. It is an initial earnings press release filed with stock exchanges rather than a full report, transcript, or regulatory certification. Therefore, it matches the Earnings Release category. FY 2026
2026-05-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 91% confidence The document is a formal letter under SEBI Regulation 30 to the stock exchanges enclosing a “Results Presentation” slide deck entitled “Investor Presentation Q4 & FY26.” It contains detailed slides on financial performance, business commentary, and outlook – characteristic of an investor presentation rather than a brief earnings release or the full annual/quarterly report. Therefore, it should be classified as an Investor Presentation (IP).
2026-05-27 English
Board approves final dividend subject to approval of Shareholders at the ensuing AGM
Interim / Quarterly Report Classification · 80% confidence The document is a SEBI Regulation 30 disclosure of Board Meeting outcomes including the approval and detailed presentation of audited financial results (standalone and consolidated) for the quarter ended March 31, 2026 (with year-to-date and year-end figures), together with the auditor’s report. It goes well beyond a simple dividend or director change notice and contains substantive financial data (income statement tables) – characteristics of an interim/quarterly report rather than just an earnings highlight or a full annual report. Therefore it should be classified as an Interim / Quarterly Report (IR). FY 2026
2026-05-27 English
Announcement under Regulation 30 (LODR)- Updates
Board/Management Information Classification · 85% confidence The document is a compliance disclosure under SEBI Listing Regulations providing two material updates: the appointment of a new President (senior management change) and details on employee fraud irregularities. The first item is clearly a senior management appointment. Under our taxonomy, announcements of changes in senior management are classified as Board/Management Information (MANG). The fraud update does not constitute legal proceedings nor a financial report, so the dominant category remains MANG.
2026-05-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.